US FDA Approves Omnipod 5 Automated Insulin Delivery System of Insulet
The Food and Drug Administration (FDA) of the United States has now given the approval to the Omnipad 5 Automated Insulin Delivery System developed by the Insulet company for the patients of type 1 diabetes from the age of six years and above, and the new system has been claiming that the new system is […]
Continue Reading